Shared Medical Appointments for Prostate Cancer Active Surveillance Follow-Up Visits
- PMID: 34841012
- PMCID: PMC8612701
- DOI: 10.1097/upj.0000000000000247
Shared Medical Appointments for Prostate Cancer Active Surveillance Follow-Up Visits
Abstract
Purpose: To accommodate for the rapidly increasing patient volume and follow-up visits of men with prostate cancer on active surveillance (AS), we carried out a quality improvement project to secure high-quality care and enhance patient experience.
Materials and methods: We proposed an innovative clinic systems redesign - "Shared Medical Appointments" (SMAs) - in which multiple patients were seen in a group format at the same time by the health care team led by a urologist leading the Institution's AS program.
Results: We piloted four SMAs during July-November 2019. Running the SMAs was feasible and improved the contact time for each patient while at the same time being time- and resource efficient for the healthcare providers and using the standard billing processes. The group dynamic was open and pleasant. The majority of patients rated their overall experience with SMA as excellent. Almost all patients responded that they were likely or very likely to attend another SMA in the future. All patients said that they would either definitely or probably recommend this visit type to a friend of family member with prostate cancer. Most patients rated their overall satisfaction with the SMA as extremely high.
Conclusions: Utilizing SMAs for AS follow-up visits was feasible and acceptable. Our promising findings suggest that SMAs can ensure high-quality patient care. Well-controlled studies comparing SMAs to individual usual care visits should be conducted with endpoints including knowledge, patient and staff satisfaction, anxiety and quality-of-life outcomes, AS adherence, process measures and resource utilization.
Keywords: active surveillance; patient satisfaction; prostate cancer; shared medical appointments.
Conflict of interest statement
Conflict of interest disclosures: A.V. is named on a patent for a statistical method to detect prostate cancer. The method has been commercialized by OPKO Health. A.V. receives royalties from sales of the test. A.V. has stock options in OPKO Health. He has received consulting fees from Ingishtec and Steba. B.E. reports consultant fees from Myriad Genetics and honorarium from Koelis, outside the submitted work. No other author has any conflicts of interest to declare.
Comment in
-
Socioeconomic Factors, Urological Epidemiology and Practice Patterns.J Urol. 2022 Mar;207(3):724-725. doi: 10.1097/JU.0000000000002373. Epub 2021 Dec 16. J Urol. 2022. PMID: 34911340 No abstract available.
-
Socioeconomic Factors, Urological Epidemiology, and Practice Patterns.J Urol. 2023 Aug;210(2):371-373. doi: 10.1097/JU.0000000000003534. Epub 2023 May 16. J Urol. 2023. PMID: 37192388 No abstract available.
References
-
- Schmucker D. Group Medical Appointments Jones and Bartlett Publishers, Inc. 2006.
-
- Noffsinger E. The ABCs of Group Visits - An Implementation Manual For Your Practice. New York. 2013.
-
- Jones S, Rackly R, Vasavada S. The group shared appointment: how it works and how it helps: new model of care increases patient access and service and improves clinical efficiency. Urology Times. 2005;33(9):15.
-
- Rhee E, Baum N. The shared medical appointment: a proposed model of medical appointments. J Med Pract Manage. 2013;29(3):172–5. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
